1. Home
  2. VTAK vs SPRC Comparison

VTAK vs SPRC Comparison

Compare VTAK & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Catheter Precision Inc.

VTAK

Catheter Precision Inc.

HOLD

Current Price

$1.23

Market Cap

2.2M

Sector

Health Care

ML Signal

HOLD

Logo SciSparc Ltd.

SPRC

SciSparc Ltd.

HOLD

Current Price

$3.01

Market Cap

1.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTAK
SPRC
Founded
2002
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
1.9M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
VTAK
SPRC
Price
$1.23
$3.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
194.6K
9.3K
Earning Date
05-13-2026
03-23-2026
Dividend Yield
N/A
N/A
EPS Growth
89.53
N/A
EPS
N/A
N/A
Revenue
$442,000.00
N/A
Revenue This Year
$1,170.33
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
3057.14
N/A
52 Week Low
$0.15
$0.25
52 Week High
$4.31
$8.90

Technical Indicators

Market Signals
Indicator
VTAK
SPRC
Relative Strength Index (RSI) 47.71 45.22
Support Level $1.14 $1.65
Resistance Level $2.08 $3.32
Average True Range (ATR) 0.12 0.28
MACD 0.04 -0.19
Stochastic Oscillator 74.42 11.83

Price Performance

Historical Comparison
VTAK
SPRC

About VTAK Catheter Precision Inc.

Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.

About SPRC SciSparc Ltd.

SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

Share on Social Networks: